3-chloro-2-[[[(3S)-oxolan-3-yl]amino]methyl]-7-(1H-pyrazol-5-yl)-1H-pyrrolo[3,2-c]quinolin-4-amine
C19H19ClN6O — CID 158909572
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-chloro-2-[[[(3S)-oxolan-3-yl]amino]methyl]-7-(1H-pyrazol-5-yl)-1H-pyrrolo[3,2-c]quinolin-4-amine
3-chloro-2-[[[(3S)-oxolan-3-yl]amino]methyl]-7-(1H-pyrazol-5-yl)-1H-pyrrolo[3,2-c]quinolin-4-amine (PubChem CID 158909572) has the molecular formula C19H19ClN6O and a molecular weight of 382.86 g/mol. Its IUPAC name is 3-chloro-2-[[[(3S)-oxolan-3-yl]amino]methyl]-7-(1H-pyrazol-5-yl)-1H-pyrrolo[3,2-c]quinolin-4-amine.
Molecular Properties
| Compound Name | 3-chloro-2-[[[(3S)-oxolan-3-yl]amino]methyl]-7-(1H-pyrazol-5-yl)-1H-pyrrolo[3,2-c]quinolin-4-amine |
|---|---|
| PubChem CID | 158909572 |
| Molecular Formula | C19H19ClN6O |
| Molecular Weight | 382.86 g/mol |
| Exact Mass | 382.13 |
| IUPAC Name | 3-chloro-2-[[[(3S)-oxolan-3-yl]amino]methyl]-7-(1H-pyrazol-5-yl)-1H-pyrrolo[3,2-c]quinolin-4-amine |
| SMILES | Nc1nc2cc(-c3ccn[nH]3)ccc2c2[nH]c(CN[C@H]3CCOC3)c(Cl)c12 |
| InChI | InChI=1S/C19H19ClN6O/c20-17-15(8-22-11-4-6-27-9-11)24-18-12-2-1-10(13-3-5-23-26-13)7-14(12)25-19(21)16(17)18/h1-3,5,7,11,22,24H,4,6,8-9H2,(H2,21,25)(H,23,26)/t11-/m0/s1 |
| InChIKey | JGLXLIVUSLYDFC-NSHDSACASA-N |
| XLogP | 3.22 |
| TPSA | 104.64 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 27 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 382.86 |
| LogP ≤ 5 | 3.22 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158909572 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.